Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - NET CHANGE IN CASH
Net Change in Cash TRVI - Trevi Therapeutics, Inc.
1.7 M
LAST VALUE
43.88%
2 YEAR CAGR
-49.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR